社会医療法人財団石心会 川崎幸病院は、川崎市南部にある病院である。2013年4月1日に川崎南部二次医療圏における地域医療支援病院の承認を受けた。

During the past decade, Kawasaki Saiwai Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kawasaki Saiwai Hospital" are "Aortic Stenosis Symptomatic" (1 trials), "Intra-abdominal Infections" (1 trials) and "Moderate Aortic Valve Stenosis" (1 trials). Many other conditions were trialed in "Kawasaki Saiwai Hospital" in a lesser frequency.

Most popular intervention types in "Kawasaki Saiwai Hospital" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ceftriaxone sodium" (1 trials), "Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT)" (1 trials) and "Metronidazole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kawasaki Saiwai Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kawasaki Saiwai Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kawasaki Saiwai Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kawasaki Saiwai Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".